Core Insights - Inspira Technologies has announced two key leadership appointments to enhance its global commercialization and governance, with Mr. Mike Hershkovitz as Vice President of Global Sales and Ms. Sivan Matza as an independent director on the board [1][4][5] Leadership Appointments - Mr. Mike Hershkovitz brings nearly two decades of experience in U.S. and international healthcare markets, having held senior roles at Johnson & Johnson and other global med-tech organizations [3] - Ms. Sivan Matza, a director at a leading international investment management firm, has extensive experience in global finance, regulation, and accounting, which will strengthen Inspira's governance framework [2] Strategic Implications - The appointments are seen as a strategic step to enhance Inspira's capabilities, with a focus on accelerating commercial expansion and strengthening governance [4][5] - The combined expertise of the new appointees is expected to serve as a powerful catalyst for Inspira's next phase of growth and execution [5] Company Overview - Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions, with FDA-cleared products including the INSPIRA™ ART100 system for cardiopulmonary bypass and ECMO procedures [7] - The company is also developing the INSPIRA ART500 system and the HYLA™ blood sensor platform, positioning itself as an attractive player in the life-support and MedTech landscape [7]